Dráulio Barros de Araújo: Rapid Effects of Ayahuasca in Treatment-Resistant Depression

Ayahuasca is evaluated for its rapid antidepressant effects in patients suffering from treatment-resistant depression. Initial research involved a six-patient, open-label trial showing a significant decrease in depressive symptoms as early as one day after a single dose. A subsequent follow-up study with 17 patients confirmed these results. These studies utilized the MADRS and Hamilton Depression rating scales to assess symptom reduction, as well as SPECT imaging to identify changes in blood flow within brain regions such as the nucleus accumbens, which are critical in depression. While the results appeared robust, the lack of a placebo control group presented a challenge for scientific validation, given potential placebo effects in such cohorts.